Vimarsana
Biggest News Aggregation in the World

Page 4 - Benefit Managers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benefit Managers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benefit Managers Today - Breaking & Trending Today

Letters: Why is only Iowa investigating sports betting? - Vimarsana News

Letters: Why is only Iowa investigating sports betting?

Letters to the editor for Aug. 14-20, 2023

Source: yahoo.com
End-of-Year Health Care Congressional Activities | Brownstein Hyatt Farber Schreck - Vimarsana News

End-of-Year Health Care Congressional Activities | Brownstein Hyatt Farber Schreck

Congress has concluded a flurry of activity ahead of the August recess, which includes considering dozens of key public health programs that expire on Sept. 30, including Community...

Duval Democratic chair: Is Gov. DeSantis raising Florida's prescription drug costs? - Vimarsana News

Duval Democratic chair: Is Gov. DeSantis raising Florida's prescription drug costs?

Chair of Duval County Democratic Party weighs in on recent legislation aimed at controlling drug prices — and how it may actually do the opposite.

Source: yahoo.com
Carper, Grassley introduce bipartisan bill to strengthen PBM oversight - Vimarsana News

Carper, Grassley introduce bipartisan bill to strengthen PBM oversight

Sens. Tom Carper (D-Del.) and Chuck Grassley (R-Iowa) introduced legislation on Thursday aimed at providing the federal government with more power to oversee pharmacy benefit managers (PBM) amid continued bipartisan scrutiny over the companies’ role in drug pricing. The two lawmakers introduced the PBM Oversight Act of 2023, which would give the Centers for Medicare…

Source: yahoo.com
FTC: Amgen-Horizon Deal Would Cement Monopoly For Treatment Of Two Diseases - Vimarsana News

FTC: Amgen-Horizon Deal Would Cement Monopoly For Treatment Of Two Diseases

Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission's promised campaign to protect competition in the...